Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

James W. Bullock Joins CryoLife Board of Directors

CryoLife
Posted on: 26 Oct 16

ATLANTA, Oct. 25, 2016 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced the appointment of James W. Bullock to its Board of Directors effective immediately.

Pat Mackin, Chairman, President, and Chief Executive Officer,  commented, "Jim Bullock has nearly 40 years of experience in the medical device sector, including recently leading two well respected cardiac device companies, Atritech and Endocardial Solutions.  His experience spans public and private companies that have successfully developed new technologies, expanded their product portfolios, scaled their business and executed on strategic M&A transactions.  We are delighted to have him on our Board for many reasons, including his perspective on CryoLife's efforts to expand its cardiac surgery portfolio through internal projects and external business development."

Mr. Bullock said, "I am excited to be joining the Board of Directors for CryoLife.  I believe the company has a significant opportunity to expand its growth potential and drive market adoption of its high quality and focused product portfolio.  I look forward to working with the CryoLife team as the Company seeks to expand its leadership position in select cardiac markets."   

Mr. Bullock is President and CEO of Zyga Technology, Inc., a privately held medical technology company focused on the design, development and commercialization of minimally invasive products to treat under-served conditions of the lumbar spine.  Mr. Bullock is also the Chairman of the Board of Directors for Stimdia, a private company focused on research in the critical care market.  Prior to Zyga, from 2005 to 2011, Mr. Bullock was President and CEO of Atritech, Inc., a medical device company that commercialized the first left atrial appendage closure device and was acquired by Boston Scientific in 2011.  From 1997 to 2005, Mr. Bullock was President and CEO of Endocardial Solutions, Inc., a publicly-traded cardiac medical device company that was acquired by St. Jude Medical in 2005.  Mr. Bullock received his Bachelors in Public Administration from the University of Arizona. 

About CryoLife, Inc.

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures.  CryoLife markets and sells products in more than 80 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:

 


 

CryoLife

D. Ashley Lee

Executive Vice President, Chief Financial Officer

and Chief Operating Officer

Phone: 770-419-3355

The Ruth Group

Nick Laudico / Zack Kubow

646-536-7030 / 7020

nlaudico@theruthgroup.com

zkubow@theruthgroup.com

For more information:
www.cryolife.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 26/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.